Transportation and Delivery – FOB Destination

The contract pertains to the transportation and delivery of Trazodone tablets under FOB Destination terms, requiring all shipments to be carried on U.S.-flagged vessels unless specific waivers are formally approved. This obligation ensures compliance with U.S. maritime regulations and supports domestic shipping capacity. The services involve end-to-end logistics coordination to guarantee secure and timely delivery of pharmaceutical products to the designated destination without ambiguity in liability or ownership transfer, which occurs only upon arrival at the final location. The North American Industry Classification System code 484220 confirms this is a specialized freight arrangement focused on truck transportation of chemicals and pharmaceuticals. This subcontract was posted on May 13, 2026, with a firm response deadline of May 19, 2026, and is managed under the Department of Defense through the Medical Supply Chain Pharm FSA. While details such as contact information, specific delivery locations, and set-aside classifications are not specified, the requirement for U.S.-flagged vessels indicates a strong emphasis on national security and supply chain integrity. The contract is accessible via the DIBBS platform, signaling its formal placement within the Department of Defense’s procurement system for critical medical logistics.